Author at Microdose

Emma Stone

Hi there! I'm a journalist specializing in cannabis and psychedelics. I also hold a PhD in sociology, which has served me well when it comes to researching scholarly material and communicating it in an engaging, accessible way. I'd welcome the opportunity to contribute to Microdose on a regular basis, and have included some relevant recent samples of my writing below. Looking forward to hearing from you, Warmly, Emma

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Science

7 Dec 2022

Tripping Without The Trip: Non-Hallucinogenic Psychedelics

What happens if you remove the trip from psychedelic experiences? Do non-hallucinogenic psychedelic experiences give the same therapeutic advantages?...

By Emma Stone

Law & Politics

24 Nov 2022

Right-to-Try Psilocybin: Legal Battle With DEA Continues

Two years ago, Dr....

By Emma Stone

Law & Politics

15 Nov 2022

Alberta’s Psychedelic Therapy Laws: What Are the Implications?

Alberta made history on October 5th, 2022 when the government became the first province in Canada to regulate psychedelic therapy....

By Emma Stone

Science

18 Oct 2022

Can LSD Make You Smarter? New Study Shows Positive Results

Humans are always on the hunt for life hacks, whether it’s getting fitter, slimmer, or more beautiful....

By Emma Stone

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture, Industry

15 Sep 2022

New Survey Shows Psychedelic Use At Record High

While enthusiastic researchers, psychonauts and high-profile influencers sing the praises of psychedelics, how do everyday people interact with these once-stigmatized substances? How has the growing momentum of the psychedelic renaissance...

By Emma Stone

Industry, Science

25 Aug 2022

Anchoring Peak Experience: The World’s First Study of VR and Psychedelics

Virtual Reality and Psychedelics: A new frontier in mind medicine?...

By Emma Stone

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

11 Aug 2026

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the antidepressant benefits people associate with psychedelics without the trip? On...

By Madison Roberts

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

13 Jul 2026

The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet

The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicated....

By Madison Roberts

28 May 2026

Medical Psilocybin Act

New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal access to psilocybin therapy for conditions like PTSD, treatment-resistant depression, substance use disorders, end-of-life distress,...

By Madison Roberts

5 May 2026

PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field

By Madison Roberts

21 Apr 2026

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does something the psychedelic industry has been waiting for, and quietly fearing. It removes ambiguity. For...

By Madison Roberts

Hi there! I'm a journalist specializing in cannabis and psychedelics. I also hold a PhD in sociology, which has served me well when it comes to researching scholarly material and communicating it in an engaging, accessible way. I'd welcome the opportunity to contribute to Microdose on a regular basis, and have included some relevant recent samples of my writing below. Looking forward to hearing from you, Warmly, Emma

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads